LBIO (Longevity Biomedical) Days Inventory: 0.00 (As of . 20)


What is Longevity Biomedical Days Inventory?

Longevity Biomedical LBIO Days Inventory is 0.00 as of . 20.

Days Inventory is also known as Days Sales of Inventory (DSI). Longevity Biomedical's Average Total Inventories for the six months ended in . 20 was $0.00 Mil. Longevity Biomedical's Cost of Goods Sold for the six months ended in . 20 was $0.00 Mil.

The historical rank and industry rank for Longevity Biomedical's Days Inventory or its related term are showing as below:

LBIO's Days Inventory is not ranked *
in the Biotechnology industry.
Industry Median: 183.195
* Ranked among companies with meaningful Days Inventory only.

Longevity Biomedical's Days Inventory stayed the same from . 20 (0.00) to . 20 (0.00).

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.


Longevity Biomedical  (NAS:LBIO) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Longevity Biomedical's Inventory Turnover for the six months ended in . 20 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Longevity Biomedical's Inventory to Revenue for the six months ended in . 20 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Longevity Biomedical Days Inventory Related Terms


Longevity Biomedical Days Inventory Historical Data

* Premium members only.

The historical data trend for Longevity Biomedical's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Longevity Biomedical Days Inventory Chart

Longevity Biomedical Annual Data
Trend
Days Inventory

Longevity Biomedical Semi-Annual Data
Days Inventory

LBIO vs : Days Inventory Comparison

For the Biotechnology subindustry, Longevity Biomedical's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Longevity Biomedical Days Inventory vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Longevity Biomedical's Days Inventory distribution charts can be found below:

* The bar in red indicates where Longevity Biomedical's Days Inventory falls into.



Longevity Biomedical Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Longevity Biomedical's Days Inventory for the fiscal year that ended in . 20 is calculated as

Days Inventory (A: . 20 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: . 20 ) + Total Inventories (A: . 20 )) / count ) / Cost of Goods Sold (A: . 20 )*Days in Period
=( ( + ) / 1 ) / *365
=0 / *365
=N/A

Longevity Biomedical's Days Inventory for the quarter that ended in . 20 is calculated as:

Days Inventory (Q: . 20 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: . 20 ) + Total Inventories (Q: . 20 )) / count ) / Cost of Goods Sold (Q: . 20 )*Days in Period
=( ( + ) / 1 ) / *365 / 2
=0 / *365 / 2
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Inventory →
What does a Days Inventory of 0.00 mean?
Longevity Biomedical (LBIO) has a Days Inventory of 0.00 as of . 20. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Longevity Biomedical and its competitors.
Is Longevity Biomedical's Days Inventory too high?
Longevity Biomedical's current Days Inventory is 0.00.
How does Longevity Biomedical's Days Inventory compare to ?
Longevity Biomedical's Days Inventory of 0.00 can be compared against companies in the Biotechnology industry. The industry median Days Inventory is 183.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Longevity Biomedical and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Longevity Biomedical's current Days Inventory is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Longevity Biomedical stock overvalued right now?
Longevity Biomedical (LBIO) has a current Days Inventory of 0.00. The current Days Inventory is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Longevity Biomedical (LBIO), the current Days Inventory is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Longevity Biomedical Business Description

Comparable Companies
Address 12100 NE 195th street, Suite 150, Bothell, WA, USA, 98011
Longevity Biomedical Inc is a clinical-stage biomedical company. The company is focused on the advancement of new technologies across therapeutics, monitoring, and digital health that aim to restore tissue form and function to increase health span. Longevity is acquiring a differentiated therapeutic pipeline of late-stage clinical technologies across ophthalmology, cardiovascular disease, and soft tissue reconstruction and repair.